Objective: The study was designed to replicate and extend pervious findings demonstrating the high rates of invalid neuropsychological testing in military service members (SMs) with a history of mild traumatic brain injury (mTBI) assessed in the context of a medical evaluation board (MEB). Method: Two hundred thirty-one active duty SMs (61 of which were undergoing an MEB) underwent neuropsychological assessment. Performance validity (Word Memory Test) and symptom validity (MMPI-2-RF) test data were compared across those evaluated within disability (MEB) and clinical contexts. Results: As with previous studies, there were significantly more individuals in an MEB context that failed performance (MEB = 57%, non-MEB = 31%) and symptom validity testing (MEB = 57%, non-MEB = 22%) and performance validity testing had a notable affect on cognitive test scores. Performance and symptom validity test failure rates did not vary as a function of the reason for disability evaluation when divided into behavioral versus physical health conditions. Conclusions: These data are consistent with past studies, and extends those studies by including symptom validity testing and investigating the effect of reason for MEB. This and previous studies demonstrate that more than 50% of SMs seen in the context of an MEB will fail performance validity tests and over-report on symptom validity measures. These results emphasize the importance of using both performance and symptom validity testing when evaluating SMs with a history of mTBI, especially if they are being seen for disability evaluations, in order to ensure the accuracy of cognitive and psychological test data.
Introduction
Military service members (SM) are required to maintain medical retention standards designed to assure that they are physically, cognitively, and mentally capable of performing the tasks associated with their military specific duties. When a SM has a medical condition that might render him/her unable to meet these standards, the SM is entered into the Integrated Disability Evaluation System (IDES) and undergoes a Medical Evaluation Board (MEB) to determine fitness for duty. This is essentially a disability evaluation that could result in a medical separation from the armed services. In MEB evaluations of soldiers with a history of mild traumatic brain injury (mTBI), neuropsychological testing is typically a core component of the MEB process, even if the MEB is not for reasons related to the mTBI. Other types of disability evaluations (such as workers compensation claims for mTBI, orthopedic conditions, and behavioral health diagnoses) have demonstrated high rates of invalid neuropsychological test performances (Gervais, Ben-Porath, Wygant, & Green, 2007; Green, Rohling, Lees-Haley, & Allen, 2001 ). Two recent papers have evaluated neuropsychological performance and symptom validity testing in the context of MEBs.
Armistead-Jehle and Buican (2012) evaluated performance validity test (PVT) results (as measured by the Word Memory Test [WMT; Green, 2003] ) and various cognitive measures in 335 active duty SMs as a function of MEB versus clinical evaluation context. Significantly more SMs in the midst of an MEB scored below WMT cut scores suggesting invalid performance (54%), relative to those evaluated in a non-MEB/clinical context (35%). Additionally, it was shown that regardless of MEB versus non-MEB status, PVT results had a remarkable negative influence on various cognitive domains (in particular memory, attention and processing speed), with effect sizes as high as d = 1.17. These authors also evaluated symptom validity testing (SVT), as measured by the over-reporting scales of the Personality Assessment Inventory (PAI; Morey, 1991) . They demonstrated significantly higher Negative Impression Management scale scores in those who did not pass the WMT relative to those that did, with a moderate effect size. However the authors did not evaluate SVT scores as a function of MEB versus clinical context, independent of PVT results. Grills and Armistead-Jehle (2016) sought to replicate these findings in an independent sample of active duty military SMs with a history of concussion. Five hundred eighty-nine service members seen for neuropsychological evaluation were administered the WMT and the Neuropsychological Assessment Battery-Screening Module (NAB-SM; Stern & White, 2003) . Of this sample 54 were in the midst of an MEB. As with the Armistead-Jehle and Buican (2012) study, significantly more SMs in the disability context failed the WMT (52%), relative to those seen in a non-MEB/clinical context (37%). Moreover, PVT results had a notable influence across NAB-SM test domains with effect sizes ranging from d = 0.5 to 1.0. In short, the Grills and Armistead-Jehle data closely matched the Armistead-Jehle and Buican data in highlighting not only the elevated base rate of invalid test performances in SMs undergoing MEBs, but also the notable affect of test validity (as measured by PVTs) on cognitive test results.
The aim of the current study was to replicate these previous investigations with an independent sample and to extend these findings by more closely examining SVT results as a function of MEB versus clinical status. Additionally, we wished to further extend the previous research by examining whether or not the reason for MEB (dichotomized as behavioral health [BH] versus physical health [PH] ) influenced PVT and SVT results.
Methods

Participants and Procedures
The investigation was a retrospective review of a convenience sample of 231 U.S. Active Duty SMs who consecutively underwent neuropsychological evaluation in the same outpatient brain injury clinic at a large Atlantic Region Medical Treatment Facility between January 2014 and December 2015. The average age of the sample was 34.1 years (SD = 8.1), the majority had a high school education (78.4%), with 13.4% having earned a college degree and 8.2% a post-undergraduate degree, and most were Caucasian (88.3%). All subjects had a medically confirmed history of mild TBI as defined by the Department of Defense (Casscells, 2007) , which is akin to the American Congress of Rehabilitation Medicine (1993) criteria. TBI diagnosis and classification was made by the evaluating neuropsychologist based on available medical records and clinical interview. All evaluations were done, six months or more from the date of injury, with their brain injury clinic medical provider referring them for evaluation due to persistent symptoms. With regards to comorbid behavioral health diagnoses, 56 (24.2%) had a primary diagnosis of PTSD, 22 (9.5%) Adjustment Disorder, 21 (9.0%) Other Anxiety Disorder, 13 (5.6%) Depression, and 2 (0.9%) Alcohol Use Disorder. One hundred and seventeen subjects (50.6%) had no behavioral health diagnosis.
For select analyses, subjects were divided into MEB versus non-MEB/clinical evaluations. Sixty-one of the subjects were in the midst of an MEB. Additional select analyses required further sub-dividing the MEB group into those with a BH related reason for MEB and a PH related reason for the MEB. Of those in the MEB group, 16 were related to only BH conditions, 42 were related to only PH conditions, and three were being medically boarded for both a BH and a PH condition. The overwhelming majority of PH reasons for MEB (91%) related to various orthopedic injures (e.g., knee, shoulder, feet, wrist, hip, neck, or back). The other reason for PH MEB related to headaches. All BH reasons for MEB related to PTSD, Depression, and/or Anxiety. (Meyers & Meyers, 1995) . Subjects were also administered the MMPI-2-RF (Ben-Porath & Tellegen, 2008 , 2011 with the following symptom validity scales included in the current analysis: Infrequent Responses (F-r), Infrequent Psychopathology Responses (Fp-r), Infrequent Somatic Responses (Fs), Symptom Validity (FBS-r), and the Response Bias Scale (RBS).
Procedures
Performance validity was determined via results of the WMT, with the cut between passing and failing determined by the Immediate Recognition, Delayed Recognition, and Consistency scores outlined in the test manual "as a clear fail." Symptom validity was determined via results on the MMPI-2-RF, with invalid reporting defined as F-r > 99 or Fp-r > 79 or Fs > 99 or FBS-r > 99 or RBS > 99. Validity criteria were defined by the highest cut score in the manual that was described as meaning "the protocol may be invalid." Given the high number of individual neuropsychological tests administered and the potentially negative influence of family-wise error, the individual cognitive measures were grouped into domains with the subsequent calculation of an average composite T-score. The entirety of the sample completed each of the cognitive measures listed above, save WAIS-IV Symbol Search, WMS-IV Logical Memory I and II, Paired Associates I and II, Visual Reproduction I and II, and Symbol Span, and D-KEFS Trail Making Test Condition 1, where data from 230 subjects was available. As such, there were not notable sample size differences that could have influenced composite scores. The composition of these domains is listed in Table 1 .
Comparisons were made between MEB and non-MEB/clinical groups as a function of PVT and SVT results. Further, in the MEB group PVT and SVT results were compared as a function of the reason for MEB (e.g., BH vs. PH condition). In an effort to examine the influence of performance validity on cognitive test results, the entire sample was divided by WMT pass/ fail criteria. Cognitive domains were then compared between the two groups. Given the multiple pairwise comparisons a Bonferroni correction of α = 0.008 was applied.
Results
Across the entire sample, the overall WMT failure rate was 37.7% (n = 87) and the overall MMPI-2-RF over-reporting rate was 31.2% (n = 72). Of those that over-reported on the MMPI-2-RF, 30 (41.7%) elevated one or more of the three F-scales, nine (12.5%) elevated only RBS, 31 (43.1%) elevated on the RBS and one or more of the F-scales and two (2.8%) elevated FBS-r, RBS, and one or more of the F-scales. Of the overall sample, 16.5% (n = 38) demonstrated invalidity on both the WMT and the MMPI-2-RF. Of those in the context of an MEB, the WMT and MMPI-2-RF failure rates were each 57.4% (n = 35). However, the correlation between these two variables was not significant (r ϕ = .06, p = .64), suggesting that despite the similar percentage, by and large, different subjects failed these measures. Of those in the midst of an MEB who overreported on the MMPI-2-RF, 13 (37.1%) elevated one or more of the three F-scales, four (11.4%) elevated only RBS, 17 (48.6%) elevated on the RBS and one or more of the F-scales and one (2.9%) elevated FBS-r, RBS, and one or more of the F-scales. Of those evaluated in a non-MEB/clinical context 30.6% failed the WMT and 22.4% evidenced over-reporting on the MMPI-2-RF. Relative to those tested in a non-MEB/clinical group, significantly more individuals in the MEB group failed the WMT (Χ 2 = 13.7, p < .001) and had MMPI-2-RF profiles indicative of over-reporting (Χ 2 = 25.1, p < .001). The PVT and SVT failure rates for those being evaluated for BH related conditions were 56.3% and 62.5%, respectively. The PVT and SVT failure rates for those being evaluated for PH conditions were 52.4% and 54.8%, respectively. There were no statistically significant differences between SVT and PVT failure rates as a function of the reason for MEB (i.e., BH vs. PH). With reference to the effect of PVT results on cognitive testing, those who demonstrated invalid test performance (i.e., WMT failure) had significantly lower cognitive test scores across all domains (e.g., attention, processing speed, memory, visual and verbal reasoning, executive functioning, and overall test battery mean), with all p values ≤ .001. Effect sizes for each of these comparisons ranged from medium (d = 0.4) to large (d = 1.3; see Table 2 ).
Discussion
The current study sought to replicate and extend previous works by Armistead-Jehle and Buican (2012) and Grills and Armistead-Jehle (2016) in an independent sample of SMs with a history of mTBI. In terms of PVT, the Armistead-Jehle and Buican data showed a 54% WMT failure rate in SMs undergoing an MEB and a 35% failure rate in those evaluated in a non-MEB/clinical context, whereas the Grills and Armistead-Jehle study demonstrated 52% and 37% failure rates in SM's undergoing an MEB and non-MEB/clinical evaluations, respectively. The current data demonstrated MEB group WMT failure rates of 57% and non-MEB/clinical group failure rates of 31%. This study is then the third of its kind to demonstrate these types of percentages and taken together these data strongly suggest that a PVT baseline failure rate above 50% in SM's under evaluation for medical separation from the military. In addition, the effect of test validity (as measured by PVT performance) on cognitive testing was also notable and similar to the two previous studies. Effect sizes were largest for memory testing and the overall test battery mean. With the former, there was nearly a standard deviation difference between the groups and with the latter, just over a half standard deviation. Clinically, the average composite scores for these domains in those that failed the WMT remained in the average range; however, with the relatively high degree of variability (i.e., elevated standard deviations) many of these subjects would fall into the mildly impaired range of functioning. If PVT were not considered, one might conclude that these findings represented a decline from baseline and incorrectly render a diagnosis of cognitive impairment.
The current study extends the previous research on this topic by including SVT data and by evaluating if the reason for MEB was associated with differing PVT and SVT failure rates. In regards to the former, the rates of symptom over-reporting as measured by the MMPI-2-RF were comparable to PVT failure rates, in that roughly one third of the overall sample scored above the identified cut scores. The MEB group also demonstrated significantly higher rates of over-reporting relative to the non-MEB/Clinical group, with the former identical to the PVT failure rate of 57%, but the latter slightly less that the PVT failure rate at 22.4%. When the PVT and SVT failure rates were evaluated as a function of BH or PH condition, there were no statically significant differences across PVT or SVT data. This however could have been a result of relatively small sample sizes, particularly with regards to the fairly small number of subjects undergoing an MEB for only BH related reasons.
The current study was not without its limitations. As with the previous two studies on this topic, the current sample was composed largely of Caucasian males and these results may then have limited external validity in regards to gender and (Heilbronner, Sweet, Morgan, Larrabee, & Millis, 2009; Proto et al., 2014) . While failure on one PVT is not generally considered sufficient by the field to diagnose malingering, such a diagnosis is frequently not the intent of neuropsychological assessment in the military context. Rather the primary intent is to make reasonably certain that cognitive test data is an accurate and credible reflection of the SM's abilities, so that this information can be employed in diagnostic formulation and treatment recommendations. Still future investigations of this nature could potentially produce more robust data with the inclusion of multiple PVTs. Further, the current study had a relatively small number of subjects undergoing an MEB for BH specific reasons. This limited our ability to further evaluate symptom over-reporting as a function of MMPI-2-RF scales specific to psychiatric (F-r, F-p) versus cognitive and somatic (F-s, RBS, FBS-r) symptoms. Future studies may wish to evaluate the hypothesis that those engaged in PH related MEBs have higher rates of over reporting on somatic scales and those involved in BH related MEBs have higher rates of over-reporting on psychological scales. A final limitation of this study pertains to the MEB versus non-MEB classification. In the military system, any medical examination can ultimately be employed as part of a MEB process, even if the SM is not currently engaged in such. As a result, a refined classification of disability-seeking versus non-disability seeking is challenging to make in this population. Future studies may be able to avoid this weakness if data from groups with strong motivation to perform well on testing (e.g., aviators or Special Forces) can be obtained. Despite these limitations, the current data closely replicated previous studies by Armistead-Jehle and Buican (2012) and Grills and Armistead-Jehle (2016) . In sum, these three data sets (that include a combined sample size of over 1150 SMs) render highly similar results strongly supporting the use of PVT across non-MEB, and particularly MEB, evaluations. The current data also supports the use of SVT in such evaluations in those with a history of mTBI, regardless of the reason for MEB.
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